Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Belda-Iniesta, Cristobal"'
Autor:
Chabot P; Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada., Hsia TC; China Medical University Hospital, China Medical University, Taichung, Taiwan, People's Republic of China., Ryu JS; Inha University Hospital, Jung-Gu, Incheon, South Korea., Gorbunova V; N.N. Blokhin Russian Cancer Research Center, Moscow, Russia., Belda-Iniesta C; Centro Integral Oncológico Clara Campal HM Sanchinarro, Madrid, Spain., Ball D; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Kio E; IU Health Goshen Center for Cancer Care, Goshen, IN, USA., Mehta M; University of Maryland, College Park, MD, USA., Papp K; AbbVie Inc., Chicago, IL, USA., Qin Q; AbbVie Inc., Chicago, IL, USA., Qian J; AbbVie Inc., Chicago, IL, USA., Holen KD; AbbVie Inc., Chicago, IL, USA., Giranda V; AbbVie Inc., Chicago, IL, USA., Suh JH; Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195, USA. suhj@ccf.org.
Publikováno v:
Journal of neuro-oncology [J Neurooncol] 2017 Jan; Vol. 131 (1), pp. 105-115. Date of Electronic Publication: 2016 Sep 21.
Autor:
García-Romero N; Instituto Madrileño de Estudios Avanzados, IMDEA Nanociencia, Madrid, Spain., González-Tejedo C; Centro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain., Carrión-Navarro J; Fundación de Investigación HM Hospitales, HM Hospitales, Madrid, Spain., Esteban-Rubio S; Instituto de Medicina Molecular Aplicada (IMMA), School of Medicine, San Pablo-CEU University, Campus de Montepríncipe, Madrid, Spain., Rackov G; Instituto Madrileño de Estudios Avanzados, IMDEA Nanociencia, Madrid, Spain., Rodríguez-Fanjul V; Instituto Madrileño de Estudios Avanzados, IMDEA Nanociencia, Madrid, Spain., Oliver-De La Cruz J; International Clinical Research Center, Center for Translational Medicine, St. Anne's University Hospital, Brno, Czech Republic., Prat-Acín R; Neurosurgery Department, Hospital Universitario la Fe de Valencia, Valencia, Spain., Peris-Celda M; Neurosurgery Department, Hospital Universitario la Fe de Valencia, Valencia, Spain., Blesa D; Genetic and Genomic Unit, Fundación Centro de Investigación Príncipe Felipe, Valencia, Spain., Ramírez-Jiménez L; Genetic and Genomic Unit, Fundación Centro de Investigación Príncipe Felipe, Valencia, Spain., Sánchez-Gómez P; Neuro-Oncology Unit, Instituto de Salud Carlos III-UFIEC, Madrid, Spain., Perona R; Instituto de Investigaciones Biomédicas, CIBERER, CSIC/UAM, Madrid, Spain., Escobedo-Lucea C; Division of Biopharmaceutics and Pharmacokinetics, University of Helsinki, Helsinki, Finland., Belda-Iniesta C; Fundación de Investigación HM Hospitales, HM Hospitales, Madrid, Spain., Ayuso-Sacido A; Instituto Madrileño de Estudios Avanzados, IMDEA Nanociencia, Madrid, Spain.; Fundación de Investigación HM Hospitales, HM Hospitales, Madrid, Spain.; Instituto de Medicina Molecular Aplicada (IMMA), School of Medicine, San Pablo-CEU University, Campus de Montepríncipe, Madrid, Spain.
Publikováno v:
Oncotarget [Oncotarget] 2016 Oct 04; Vol. 7 (40), pp. 65888-65901.
Autor:
López-Ayllón BD; Instituto de Investigaciones Biomédicas CSIC/UAM; Biomarkers and Experimental Therapeutics in Cancer, IdiPaz Madrid, Spain., de Castro-Carpeño J; Department of Medical Oncology, La Paz University Hospital, IdiPaz Madrid, Spain., Rodriguez C; Cancer Epigenetics Laboratory, INGEMM, Biomarkers and Experimental Therapeutics in Cancer, IdiPaz, La Paz University Hospital Madrid, Spain., Pernía O; Cancer Epigenetics Laboratory, INGEMM, Biomarkers and Experimental Therapeutics in Cancer, IdiPaz, La Paz University Hospital Madrid, Spain., Ibañez de Cáceres I; Cancer Epigenetics Laboratory, INGEMM, Biomarkers and Experimental Therapeutics in Cancer, IdiPaz, La Paz University Hospital Madrid, Spain., Belda-Iniesta C; Department of Medical Oncology, Madrid Norte Sanchinarro University Hospital Madrid, Spain., Perona R; Instituto de Investigaciones Biomédicas CSIC/UAM; Biomarkers and Experimental Therapeutics in Cancer, IdiPaz Madrid, Spain ; CIBER de Enfermedades Raras Valencia, Spain., Sastre L; Instituto de Investigaciones Biomédicas CSIC/UAM; Biomarkers and Experimental Therapeutics in Cancer, IdiPaz Madrid, Spain ; CIBER de Enfermedades Raras Valencia, Spain.
Publikováno v:
International journal of clinical and experimental pathology [Int J Clin Exp Pathol] 2015 Mar 01; Vol. 8 (3), pp. 2888-98. Date of Electronic Publication: 2015 Mar 01 (Print Publication: 2015).
Autor:
Lopez-Ayllon BD; Instituto de Investigaciones Biomédicas CSIC/UAM, Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Spain., Moncho-Amor V, Abarrategi A, Ibañez de Cáceres I, Castro-Carpeño J, Belda-Iniesta C, Perona R, Sastre L
Publikováno v:
Cancer medicine [Cancer Med] 2014 Oct; Vol. 3 (5), pp. 1099-111. Date of Electronic Publication: 2014 Jun 25.
Autor:
Belda-Iniesta, Cristobal, Casado, Enrique, de la Calle, Miriam Corral, Barón, Manuel Gonzalez, Corral de la Calle, Miriam, Castelo, Beatriz, Barón, Manuel González
Publikováno v:
JNCI: Journal of the National Cancer Institute; 3/5/2003, Vol. 95 Issue 5, p410-410, 1p